Some time after 9am on Tuesday 21st July 2009.
Announcement after a trading halt:
'PRIMA BIOMED COMPLETES A$25.5 MILLION CONVERTIBLE NOTE
FUNDING'
Funding has been Prima Biomeds biggest issue which is why it reached a SP of 0.005 and anyone who has had a look at their balance sheets and not seen $20m or so to spend on trials and development should realise they need the money from somewhere and that dilution will occur and this SHOULD already be factored in to some degree.
Hope this helps
Regards
dc
- Forums
- ASX - By Stock
- IMM
- trading analysis is prr positive
IMM
immutep limited
Add to My Watchlist
2.00%
!
24.5¢

trading analysis is prr positive, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
24.5¢ |
Change
-0.005(2.00%) |
Mkt cap ! $357.7M |
Open | High | Low | Value | Volume |
25.0¢ | 25.0¢ | 24.0¢ | $419.2K | 1.737M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 301706 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
24.5¢ | 28117 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 192523 | 0.240 |
5 | 298882 | 0.235 |
10 | 327911 | 0.230 |
13 | 511200 | 0.225 |
17 | 1170248 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.245 | 8320 | 1 |
0.250 | 161392 | 6 |
0.255 | 106804 | 5 |
0.260 | 253203 | 7 |
0.265 | 486184 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online